Hypoxia-mediated apoptosis in oral carcinoma cells occurs via two independent pathways

Molecular Cancer

Volumn 3, Issue , 2004, Pages

  Nagaraj, Nagathihalli S ^a   Vigneswaran, Nadarajah ^b   Zacharias, Wolfgang ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 10; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DEATH RECEPTOR; DNA FRAGMENT; INTERLEUKIN 1BETA CONVERTING ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; CASPASE; CYSTEINE PROTEINASE INHIBITOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CELL GROWTH; CELL HYPOXIA; CONTROLLED STUDY; CYTOSOL; DRUG DESIGN; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MITOCHONDRION; MOUTH CARCINOMA; NICK END LABELING; NUCLEOSOME; PROTEIN DEGRADATION; TIME; AGED; CARCINOMA; DNA FRAGMENTATION; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

AGED; APOPTOSIS; CARCINOMA; CASPASES; CELL HYPOXIA; CELL LINE, TUMOR; CYSTEINE PROTEINASE INHIBITORS; CYTOCHROMES C; DNA FRAGMENTATION; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLY(ADP-RIBOSE) POLYMERASES; SIGNAL TRANSDUCTION;

EID: 13644258650     PISSN: 14764598     EISSN: None     Source Type: Journal    
DOI: 10.1186/1476-4598-3-38     Document Type: Article

References (52)

1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993, 54:594-606.
2. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 1999, 49:33-36.
3. Harris AL: Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002, 2:38-47.
4. Weinmann M, Jendrossek V, Handrick R, Guner D, Goecke B, Belka C: Molecular ordering of hypoxia-induced apoptosis: critical involvement of the mitochondrial death pathway in a FADD/caspase-8 independent manner. Oncogene 2004, 23:3757-3769.
5. Li C, Jackson RM: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol 2002, 282:C227-C241.
6. Fischer U, Janicke RU, Schulze-Osthoff K: Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 2003, 10:76-100.
7. Regula KM, Ens K, Kirshenbaum LA: Mitochondria-assisted cell suicide: a license to kill. J Mol Cell Cardiol 2003, 35: 59-567.
8. Dempsey PW, Doyle SE, He JQ, Cheng G: The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003, 14:193-209.
9. Borner C: The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 2003, 39:615-647.
10. Engels IH, Stepczynska A, Stroh C, Lauber K, Berg C, Schwenzer R, Wajant H, Janicke RU, Porter AG, Belka C, Gregor M, Schulze-Osthoff K, Wesselborg S: Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 2000, 19:4563-4573.
11. Liu X, Yue P, Zhou Z, Khuri FR, Sun SY: Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 2004, 96:1769-80.
12. Calviello G, Di Nicuolo F, Piccioni E, Marcocci ME, Serini S, Maggiano N, Jones KH, Cornwell DG, Palozza P: Gamma-Tocopheryl quinone induces apoptosis in cancer cells via caspase-9 activation and cytochrome c release. Carcinogenesis 2003, 24:427-433.
13. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 protease nomenclature. Cell 1996, 87:171-172.
14. Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, Ricci JE, Edris WA, Sutherlin DP, Green DR, Salvesen GS: A unified model for apical caspase activation. Mol Cell 2003, 11:529-541.
15. Igney FH, Krammer PH: Death and anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002, 2:277-288.
16. Gulbins E, Dreschers S, Bock J: Role of mitochondria in apoptosis. Exp Physiol 2003, 88:85-90.
17. Zhu H, McElwee-Witmer S, Perrone M, Clark KL, Zilberstein A: Phenylephrine protects neonatal rat cardiomyocytes from hypoxia and serum deprivation-induced apoptosis. Cell Death Differ 2000, 7:773-784.
18. Malhotra R, Lin Z, Vincenz C, Brosius FC: Hypoxia induces apoptosis via two independent pathways in Jurkat cells: differential regulation by glucose. Am J Physiol Cell Physiol 2001, 281: 1596-C1603.
19. Lim ML, Lum MG, Hansen TM, Roucou X, Nagley P: On the release of cytochrome c from mitochondria during cell death signaling. J Biomed Sci 2002, 9:488-506.
20. Twiddy D, Brown DG, Adrain C, Jukes R, Martin SJ, Cohen GM, Mac-Farlane M, Cain K: Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J Biol Chem 2004, 279:19665-19682.
21. Nicholson DW, Thornberry NA: Caspases: killer proteases. Trends Biochem Sci 1991, 22:299-306.
22. Janicke RU, Sprengart ML, Wati WR, Poter AG: Caspase -3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 1998, 273:9357-9360.
23. Sacks PG: Cell, tissue and organ culture as in vitro models to study the biology of squamous cell carcinomas of the head and neck. Cancer Metastasis Rev 1996, 15:27-51.
24. Bossy-Wetzel E, Newmeyer DD, Green DR: Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J 1998, 17:37-49.
25. Hockel M, Vaupel P: Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001, 93:266-276.
26. Greijer AE, van der Wall E: The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004, 57:1009-1014.
27. Gavrieli Y, Shennan Y, Ben-Sasson JA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992, 119:493-501.
28. Araya R, Uehara T, Nomura Y: Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett 1998, 439: 68-72.
29. De Moissac D, Gurevich RM, Zheng H, Singal PK, Kirshenbaum LA: Caspase activation and mitochondrial cytochrome c release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol 2000, 32:53-63.
30. Chae HJ, Kim SC, Han KS, Chae SW, An NH, Kim HM, Kim HH, Lee ZH, Kim HR: Hypoxia induces apoptosis by caspase activation accompanying cytochrome C release from mitochondria in MC3T3E1 osteoblasts. p38 MAPK is related in hypoxia-induced apoptosis. Immunopharmacol Immunotoxicol 2001, 23:133-52.
31. Gibson ME, Han BH, Choi J, Knudson CM, Korsmeyer SJ, Parsadanian M, Holtzman DM: BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways. Mol Med 2001, 7:644-655.
32. Khurana P, Ashraf QM, Mishra OP, Delivoria-Papadopoulos M: Effect of hypoxia on caspase-3, -8, and -9 activity and expression in the cerebral cortex of newborn piglets. Neurochem Res 2002, 27: 31-938.
33. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Yoshida R, Kaufman SA, Lowe SW, Penninger JM, Mak TW: Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998, 94:339-352.
34. Kuida K, Haydar TF, Kuan C-Y, Gu Y, Taya C, Karasuyama H, Su MSS, Rakic P, Flavell RA: Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 1998, 94: 25-337.
35. Nagata S, Golstein P: The Fas death factor. Science 1995, 267:1449-1456.
36. Fulda S, Meyer E, Debatin KM: Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 2000, 60: 947-3956.
37. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK, Peter ME: Molecular ordering of the initial signaling events of CD95. Mol Cell Biol 2002, 22:207-220.
38. Vigneswaran N, Wu J, Nagathihalli SN, Storthz K, Zacharias W: Differential susceptibility of metastatic and primary oral cancer cells to TRAIL-induced apoptosis. Int J Oncol 2005, 5(26 : 03-112.
39. Weinmann M, Marini P, Jendrossek V, Betsch A, Goecke B, Budach W, Belka C: Influence of hypoxia on TRAIL-induced apoptosis in tumor cells. Int J Radiat Oncol Biol Phys 2004, 58: 86-396.
40. Yaniv G, Shilkrut M, Lotan R, Berke G, Larisch S, Binah O: Hypoxia predisposes neonatal rat ventricular myocytes to apoptosis induced by activation of the Fas (CD95/Apo-1) receptor: Fas activation and apoptosis in hypoxic myocytes. Cardiovasc Res 2002, 54: 11-623.
41. Chao W, Shen Y, Li L, Rosenzweig A: Importance of FADD signaling in serum deprivation- and hypoxia-induced cardiomyocyte apoptosis. J Biol Chem 2002, 277:31639-31645.
42. Parikh NA, Katsetos CD, Ashraf QM, Haider SH, Legido A, Delivoria-Papadopoulos M, Mishra OP: Hypoxia-induced caspase-3 activation and DNA fragmentation in cortical neurons of newborn piglets: role of nitric oxide. Neurochem Res 2003, 28:1351-1357.
43. Todor A, Sharov VG, Tanhehco EJ, Silverman N, Bernabei A, Sabbah HN: Hypoxia-induced cleavage of caspase-3 and DFF45/ICAD in human failed cardiomyocytes. Am J Physiol Heart Circ Physiol 2002, 283:H990-H995.
44. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998, 281:1312-1316.
45. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
46. Li H, Zhu H, Xu CJ, Yuan J: Cleavage of BID by caspase-8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998, 94:491-501.
47. Weinmann M, Belka C, Plasswilm L: Tumour hypoxia: impact on biology, prognosis and treatment of solid malignant tumours. Onkologie 2004, 27:83-90.
48. S-Youel Park, TR. Billiar, D-W Seol: Hypoxia Inhibition of Apoptosis Induced by Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL). Biochem Biophys Res Commun 2002, 291: 50-153.
49. Slee EA, Adrain C, Martin SJ: Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ 1999, 6:1067-1074.
50. Hsu S, Singh B, Schuster G: Induction of apoptosis in oral cancer cells: agents and mechanisms for potential therapy and prevention. Oral Oncol 2004, 40:461-73.
51. Tang DG, Li L, Zhu Z, Joshi B: Apoptosis in the absence of cytochrome c accumulation in the cytosol. Biochem Biophys Res Commun 1998, 242:380-384.
52. Vigneswaran N, Wu J, Zacharias W: Upregulation of cystatin M during the progression of oral squamous cell carcinoma from primary tumor to metastasis. Oral Oncology 2003, 39:559-568.